AI-guided blood pressure trial for stage I-II hypertension
Part of Heart & circulation clinical trials.
This study tests whether combining artificial intelligence with personalized medicine can help lower blood pressure in people with stage I or II hypertension (140/90 or higher). If you have high blood pressure and can walk without help, this trial may be for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have stage I or II hypertension, meaning your blood pressure is usually 140/90 or higher.
- You can make your own decision about participating in the study.
- You can walk without a cane, wheelchair, walker, or other assistance.
- You are not pregnant.
- You are 18 years old or older.
- You are not living in an institution (like a nursing home or prison).
- You do not need extra oxygen to breathe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a computer program that helps doctors choose the most suitable blood pressure medicine for each person. If you have high blood pressure and are taking none or two types of medication, this study may help find a better treatment plan.
This trial tests a personalized approach to treating high blood pressure based on the specific causes of your condition. It aims to see if individual treatment plans are more effective than standard care.
This trial tests a computer tool that helps doctors choose the best treatment for people whose high blood pressure is not well controlled. You may join if you are on blood pressure medicine but your pressure is still too high.
This study uses artificial intelligence and a digital health app to help manage high blood pressure, high cholesterol, diabetes, kidney disease, and heart disease. It aims to help people track their health at home and receive better care recommendations through technology.
This trial tests whether a technology-enabled program (using a smartphone) helps lower blood pressure better than standard care. It may help you manage high blood pressure with guided treatment changes.
This early-stage study tests a new medication called IBI3016 to help lower blood pressure in people with mild to moderate hypertension who haven't recently taken blood pressure medications. The goal is to see if this drug is safe and effective.
Hear when a new High blood pressure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.